Koninklijke Philips NV (Koninklijke Philips NV) Debt-to-Equity

: 0.63 (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

Koninklijke Philips NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $713 Mil. Koninklijke Philips NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $7,589 Mil. Koninklijke Philips NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $13,117 Mil. Koninklijke Philips NV's debt to equity for the quarter that ended in Dec. 2023 was 0.63.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Koninklijke Philips NV's Debt-to-Equity or its related term are showing as below:

PHG' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.33 Med: 0.43 Max: 0.63
Current: 0.63

During the past 13 years, the highest Debt-to-Equity Ratio of Koninklijke Philips NV was 0.63. The lowest was 0.33. And the median was 0.43.

PHG's Debt-to-Equity is ranked worse than
79.24% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs PHG: 0.63

Koninklijke Philips NV Debt-to-Equity Historical Data

The historical data trend for Koninklijke Philips NV's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke Philips NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.42

0.50

0.42

0.55

0.63

Koninklijke Philips NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.55	N/A	0.68	N/A	0.63

Competitive Comparison

For the Medical Devices subindustry, Koninklijke Philips NV's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koninklijke Philips NV Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Debt-to-Equity falls into.

Koninklijke Philips NV Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Koninklijke Philips NV's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(713.195	+	7588.877)	/	13116.685
	=	0.63

Koninklijke Philips NV's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(713.195	+	7588.877)	/	13116.685
	=	0.63

Koninklijke Philips NV (NYSE:PHG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Koninklijke Philips NV Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Koninklijke Philips NV's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Koninklijke Philips NV (Koninklijke Philips NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Koninklijke Philips NV (NYSE:PHG) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

RYLPF:USA PHIA:Netherlands PHIA:Italy 0A2M:UK PHIAa:UK 0LNG:UK PHIA:Germany PHI1:Germany PHI1:Germany PHI1:Germany PHIA:Germany PHI1:Germany PHGN34:Brazil PHIA:Austria

Address

Philips Center, Amstelplein 2, Amsterdam, NLD, 1096 BC

Website

https://www.philips.com

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.